Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter

Aim. To evaluate the efficacy and safety of refralon (niferidil), a new class III antiarrhythmic agent whose activity is related to the block of delayed rectifying potassium current and to the prolongation of atrial and ventricular action potential and refractory periods, when it is used as an agent...

ver descrição completa

Detalhes bibliográficos

Principais autores:	E B Maĭkov, Iu A Iuricheva, N Iu Mironov, S F Sokolov, S P Golitsyn, L V Rozenshtraukh, E I Chazov
Formato:	Artigo
Idioma:	Russo
Publicado em:	"Consilium Medicum" Publishing house 2015-01-01
coleção:	Терапевтический архив
Assuntos:	refralon niferidil pharmacological cardioversion iii class antiarrhythmic agents atrial fibrillation atrial flutter.
Acesso em linha:	https://ter-arkhiv.ru/0040-3660/article/view/31674
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!